FDA advisors endorse weightloss drug Qnexa 1st new obesity in 13 years gets initial OK If the green light who would get U.S. advisers back experimental pill Diet should be approved panel says At hearing public commenters are split on drug's value Video backs diet previously rejected Advisory Panel Backs Vivus’s Gives Green Light to Pill Recommends Drug Approval of Evening News Online 02.22.12

FDA advisors endorse weight-loss drug Qnexa In a reversal, an FDA advisory committee backs the weight-loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999. Diet drug Qnexa should be approved, panel says The diet drug Qnexa has cleared a major hurdle toward eventual Food and Drug Administration approval. An independent panel of medical experts who advise the agency voted Wednesday that Qnexa's significant weight-loss benefit outweighed its potential risks. If Qnexa gets the green light, who would get the drug? An advisory committee's hearty 20-to-2 vote to recommend approval of the obesity drug Qnexa on Wednesday means it's highly likely the FDA will allow the medication to be marketed when the agency issues its final report later this year. If approved, Qnexa will be the first new prescription weight-loss medication in 13 years. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Advisory Panel Vivus Inc. (VVUS) 's weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel Vivus Inc.'s weight-loss pill Qnexa won the backing of a U.S. advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. Qnexa Weight-Loss Drug Wins Advisory Panel's Support A committee recommended that the Food and Drug Administration approve what could become the first new prescription drug to treat obesity in 13 years. FDA Weighs Fate of Qnexa for Weight Loss, Again WEDNESDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects. FDA Panel Recommends Approval of Diet Drug Qnexa A U.S. Food and Drug Administration Advisory Committee today recommended approval of the weight loss drug Qnexa, a treatment many hope will help millions of Americans who struggle with obesity. In voting  20 to 2 for approval, the committee said today that Qnexa's weight loss... At Qnexa hearing, public commenters are split on the drug's value Qnexa, an investigational drug to promote weight loss, has divided public health advocates, based on comments made Wednesday at a Food and Drug Administration advisory committee hearing. FDA Panel Votes in Favor of Weight Loss Pill Qnexa An FDA advisory committee has reversed an earlier decision and voted overwhelmingly in favor of approving the weight loss pill Qnexa.
Key Words: qnexa

References:
http://feeds.latimes.com/~r/latimes/news/science/~3/E8KkIvdBTOs/la-he-qnexa-fda-20120223,0,7015694.story
http://feeds.sfgate.com/click.phdo?i=6865f988676d333ac1c1d9b81840a91e
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1cdc94c2/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Epatients0E20A120A2220H0A0H4610A40A0Bstory0Dtrack0Frss/story01.htm
http://feeds.reuters.com/~r/reuters/topNews/~3/fCzaxVtzUkU/us-fda-obesity-vivus-idUSTRE81L2AS20120223
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1cdbd44a/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Efda0E20A120A2220H0A0H73133580Bstory0Dtrack0Frss/story01.htm
http://ChicagoTribune.feedsportal.com/c/34253/f/622900/s/1cdb3c4e/l/0L0Schicagotribune0N0Chealth0Cla0Eheb0Eqnexa0Eupdate0E20A120A2220H0A0H40A780A850Bstory0Dtrack0Frss/story01.htm
http://feeds.abcnews.com/click.phdo?i=d53bc4da23f05cb8e30b9dc15aa4830b
http://feeds.cbsnews.com/~r/CBSNewsNational/~3/K_Z_T3gGdvU/
http://pixelhat.net/